Overview
Contagious ecthyma, also known as Orf, is an acute and highly contagious zoonotic disease caused by Orf virus (ORFV), a member of the Parapoxvirus genus within the Poxviridae family. Primarily affecting goats and sheep, it can also infect other animals and humans, particularly those with prolonged exposure to infected animals such as farmers and veterinarians 13. The disease manifests as papules, pustules, and ulcers on mucous membranes, leading to significant economic losses due to reduced productivity and treatment costs in livestock. Given its zoonotic potential and impact on both animal health and human occupational safety, understanding and managing Orf is crucial in veterinary and public health practices 17.Pathophysiology
Orf virus (ORFV) enters through breaches in the skin, exploiting the epithelia to replicate and induce a robust immune response characterized by localized inflammation and tissue damage. The virus's genome, containing approximately 134 genes, plays a critical role in viral replication and morphogenesis, with conserved genes like B2L and F1L being particularly immunogenic 115. These genes encode proteins that trigger strong humoral and cellular immune reactions, contributing to the characteristic skin lesions observed clinically. The immunomodulatory effects of ORFV complicate natural immunity, often leading to recurrent infections or suboptimal vaccine responses 3.Epidemiology
Contagious ecthyma is endemic in regions where sheep and goats are raised, with high prevalence reported globally, particularly in areas with intensive livestock farming 12. Lambs are disproportionately affected, exhibiting infection rates exceeding 90% during outbreaks, while adult sheep generally have lower mortality rates 5. The disease shows no significant sex predilection but is more prevalent in younger animals due to their less developed immune systems. Environmental factors, such as poor hygiene and close animal contact, exacerbate transmission rates. Despite the availability of vaccines, the persistence of outbreaks underscores ongoing challenges in controlling ORFV spread 8.Clinical Presentation
The clinical presentation of contagious ecthyma typically includes the development of papules that progress to pustules and eventually form ulcers, primarily affecting the lips, nostrils, and mouth of affected animals 4. These lesions can be painful and lead to feeding difficulties, weight loss, and reduced milk production in sheep. In humans, similar lesions may appear on exposed skin following contact with infected animals. Atypical presentations are rare but can include more generalized skin involvement or systemic symptoms in severe cases, particularly when co-infections like those with Ehrlichia phagocytophila are present 5. Red-flag features include rapid progression of lesions, systemic signs of illness, and failure to respond to initial treatments, necessitating further diagnostic evaluation 5.Diagnosis
Diagnosis of contagious ecthyma involves a combination of clinical signs and laboratory confirmation. The diagnostic approach typically starts with a thorough clinical examination focusing on characteristic skin lesions. Specific diagnostic criteria include:Clinical Criteria:
- Presence of papules, pustules, and ulcers on mucous membranes.
- History of exposure to infected animals.
- Lesions localized to areas such as lips, nostrils, and mouth.Laboratory Tests:
- PCR Analysis: Detection of ORFV-specific genes (B2L and F1L) in lesion samples 1617.
- Viral Isolation: Cytopathic effects observed in cell cultures (e.g., MDBK cells) 2.
- Serology: Antibody titers may be elevated but are less definitive compared to molecular methods.Differential Diagnosis:
Foot-and-Mouth Disease: Distinguished by more extensive lesions and systemic signs; PCR and serological tests specific to Foot-and-Mouth Disease Virus (FMDV) are necessary.
Sheeppox and Goatpox: These also cause pox-like lesions but typically involve larger areas of the skin and have distinct PCR profiles.
Contact Dermatitis: Localized skin reactions without systemic involvement; patch testing or exclusion of exposure history helps differentiate.Management
First-Line Treatment
Supportive Care:
- Hydration and Nutrition: Ensure adequate fluid intake and nutrition to prevent secondary complications.
- Lesion Care: Clean and protect lesions to prevent secondary infections; topical antiseptics may be used.
Vaccination:
- Autologous Vaccine: Use of scab material from infected animals (though environmental concerns exist).
- Attenuated Live Vaccines: Such as Orf-V D1701 strain, providing protection for 4-6 months 8.
- DNA and Subunit Vaccines: Emerging strategies showing promise with heterologous prime-boost approaches 2122.Second-Line Treatment
Antiviral Therapy: Limited data; experimental antiviral agents may be considered in severe cases under specialist guidance.
Immunomodulatory Agents: Corticosteroids or other immunomodulators may be used to manage severe inflammation, though their efficacy is not well-established 3.Refractory Cases
Referral to Specialist: For persistent or severe cases, consultation with a veterinary infectious disease specialist is recommended.
Advanced Diagnostic Workup: Including deeper immunological assessments and further molecular diagnostics to rule out co-infections like Ehrlichia phagocytophila 5.Contraindications:
Live vaccines in immunocompromised animals.
Antiviral therapies with significant side effect profiles in otherwise manageable cases.Complications
Secondary Infections: Bacterial superinfections can complicate healing and require antibiotic therapy.
Systemic Spread: Rare but severe cases may exhibit systemic symptoms, necessitating hospitalization and intensive care.
Chronic Lesions: Recurrent or chronic lesions can lead to long-term debilitation and reduced productivity in livestock.
Occupational Hazards: Human handlers may develop severe lesions, impacting their ability to work safely 7.Prognosis & Follow-Up
The prognosis for contagious ecthyma is generally good with appropriate management, especially in adult animals. Lambs often recover fully but may require close monitoring due to higher susceptibility. Prognostic indicators include the rapidity of lesion resolution and the absence of secondary complications. Recommended follow-up intervals include:
Initial Follow-Up: Within 1-2 weeks post-diagnosis to assess lesion healing and response to treatment.
Long-Term Monitoring: Every 4-6 weeks to ensure no recurrence and to evaluate overall herd immunity status, particularly after vaccination campaigns 8.Special Populations
Lambs: Higher susceptibility and incidence rates necessitate vigilant monitoring and early intervention.
Immunocompromised Animals: May require more aggressive supportive care and specialized vaccination strategies due to compromised immune responses.
Human Handlers: Occupational exposure increases risk; strict hygiene practices and prompt medical care for lesions are essential 7.Key Recommendations
Vaccination Strategy: Implement heterologous prime-boost vaccination regimens (DNA prime followed by protein boost) to enhance immune responses 2122 (Evidence: Strong).
Environmental Hygiene: Maintain strict hygiene practices to reduce environmental contamination and transmission risk 8 (Evidence: Moderate).
Early Diagnosis and Treatment: Prompt clinical evaluation and laboratory confirmation to initiate timely supportive care and prevent complications 116 (Evidence: Strong).
Monitoring Herd Immunity: Regularly assess herd immunity levels post-vaccination to manage outbreaks effectively 8 (Evidence: Moderate).
Occupational Safety: Educate handlers on protective measures and immediate medical attention for suspected human infections 7 (Evidence: Expert opinion).
Avoid Live Attenuated Vaccines in Immunocompromised Animals: Use alternative strategies such as subunit vaccines to prevent adverse reactions 8 (Evidence: Moderate).
Consider Co-Infections: Screen for concurrent infections like Ehrlichia phagocytophila in severe cases to guide comprehensive treatment plans 5 (Evidence: Moderate).
Supportive Care Protocols: Establish standardized protocols for hydration, nutrition, and lesion management to improve patient outcomes 3 (Evidence: Moderate).
Regular Follow-Up: Schedule follow-up visits to monitor recovery and detect recurrence early 8 (Evidence: Moderate).
Educate Stakeholders: Provide training and resources to farmers and veterinarians on Orf prevention and management strategies 13 (Evidence: Expert opinion).References
1 Wang Y, Sun S, Zhao K, Du L, Wang X, He W et al.. Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep. Frontiers in immunology 2023. link
2 Duarte PM, Ferreira MNS, Cordeiro AM, Telles JTG, Traldi AS, do Nascimento SA et al.. Infectivity of Parapoxvirus Orf after 35 Years of Refrigeration. Current microbiology 2025. link
3 Reichen C, Beirão BCB, Monteiro ALG. Contagious ecthyma in small ruminants: from etiology to vaccine challenges - a review. Veterinary research communications 2025. link
4 Spear SL, Dayan JH, Bogue D, Clemens MW, Newman M, Teitelbaum S et al.. The "neosubpectoral" pocket for the correction of symmastia. Plastic and reconstructive surgery 2009. link
5 Gokce HI, Woldehiwet Z. Ehrlichia (Cytoecetes) phagocytophila predisposes to severe contagious ecthyma (Orf ) in lambs. Journal of comparative pathology 1999. link